美股市场个股详情
JAZZ 爵士制药
- 127.120
- +3.510+2.84%
收盘价 11/11 16:00 (美东)
- 126.940
- -0.180-0.14%
盘后 18:35 (美东)
76.85亿总市值18.01市盈率TTM
127.360最高价123.120最低价100.07万股成交量124.500今开123.610昨收1.26亿成交额1.71%换手率20.84市盈率(静)6045.46万总股本134.17052周最高1.84市净率74.58亿流通值99.06052周最低--股息TTM5866.78万流通股194.730历史最高--股息率TTM3.43%振幅0.515历史最低126.387平均价1股每手
关于爵士制药公司
Jazz Pharmaceuticals是一家位于爱尔兰的生物制药公司，主要专注于睡眠障碍和肿瘤的治疗。Jazz在神经科学和肿瘤适应症领域有9种获批药物;其产品组合包括治疗嗜睡症的Xyrem和Xywav，治疗转移性小细胞肺癌的Zepzelca，治疗急性淋巴细胞白血病的Rylaze，以及治疗急性髓细胞白血病的Vyxeos。2021年5月，Jazz收购了GW Pharmaceuticals，获得了其主要产品Epidiolex，用于治疗严重、罕见类型的癫痫。
公司介绍
公司代码JAZZ
公司名称爵士制药
上市日期2007/06/01
发行价格18.00
成立日期2005
CEOMr. Bruce C. Cozadd
所属市场纳斯达克
员工数量2800
年结日12-31
公司地址Waterloo Exchange,Waterloo Road,5th Floor
城市Dublin
省份都柏林
国家爱尔兰共和国
邮编4
电话353-1-634-7800
董事高管
-
姓名
- 职务
- 年薪
-
Bruce C. Cozadd
- Chairman of the Board and Chief Executive Officer
- 1534.12万
-
Philip L. Johnson
- Executive Vice President and Chief Financial Officer
- --
-
Patricia Carr
- Senior Vice President and Chief Accounting Officer
- 140.10万
-
Renee D. Gala
- President and Chief Operating Officer
- 543.44万
-
Neena M. Patil
- Executive Vice President and Chief Legal Officer
- 387.74万
-
Samantha Pearce
- Senior Vice President, Europe and International
- --
-
Liz Henderson
- Senior Vice President, Technical Operations
- --
-
Dr. Robert Iannone, M.D.
- Executive Vice President and Global Head of Research and Development
- 497.91万
-
Dr. Norbert G. Riedel,PhD
- Independent Director
- 53.38万
-
Seamus C. Mulligan
- Independent Director
- 53.13万
-
Patrick Thomas Kennedy
- Independent Director
- --
-
Heather Ann McSharry
- Independent Director
- 54.38万
-
Jennifer E. Cook
- Independent Director
- 53.38万
-
Anne O'Riordan
- Independent Director
- 52.38万
-
Laura J. Hamill
- Independent Director
- --
-
Patrick G. Enright
- Independent Director
- 52.63万
-
Kenneth W. O'Keefe
- Independent Director
- 51.38万
-
Rick E. Winningham
- Lead Independent Director
- 57.13万
-
Dr. Mark D. Smith, M.D.
- Independent Director
- 52.13万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据